Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
Signorelli SS, Fatuzzo P, Rapisarda F, Neri S, Ferrante M, Oliveri Conti G, Fallico R, Di Pino L, Pennisi G, Celotta G, Massimiliano A. Signorelli SS, et al. Among authors: rapisarda f. Drugs Aging. 2006;23(3):263-70. doi: 10.2165/00002512-200623030-00008. Drugs Aging. 2006. PMID: 16608381 Clinical Trial.
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Zoccali C, et al. Among authors: rapisarda f. J Am Soc Nephrol. 2002 Jan;13(1):134-141. doi: 10.1681/ASN.V131134. J Am Soc Nephrol. 2002. PMID: 11752030
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
Signorelli SS, Fatuzzo P, Rapisarda F, Neri S, Ferrante M, Oliveri Conti G, Fallico R, Di Pino L, Pennisi G, Celotta G, Anzaldi M. Signorelli SS, et al. Among authors: rapisarda f. Kidney Blood Press Res. 2006;29(2):100-7. doi: 10.1159/000094363. Epub 2006 Jun 30. Kidney Blood Press Res. 2006. PMID: 16809937 Clinical Trial.
Circulating E-selectin as a risk marker in patients with end-stage renal disease.
Malatino LS, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, Leonardis D, Tripepi G, Mallamaci F, Zoccali C. Malatino LS, et al. Among authors: rapisarda f. J Intern Med. 2007 Oct;262(4):479-87. doi: 10.1111/j.1365-2796.2007.01841.x. J Intern Med. 2007. PMID: 17875185 Free article.
120 results